지원사업
학술연구/단체지원/교육 등 연구자 활동을 지속하도록 DBpia가 지원하고 있어요.
커뮤니티
연구자들이 자신의 연구와 전문성을 널리 알리고, 새로운 협력의 기회를 만들 수 있는 네트워킹 공간이에요.
논문 기본 정보
- 자료유형
- 학술저널
- 저자정보
- 저널정보
- 대한소아혈액종양학회 Clinical Pediatric Hematology-Oncology Clinical Pediatric Hematology-Oncology Vol.29 No.1
- 발행연도
- 2022.4
- 수록면
- 21 - 24 (4page)
- DOI
- 10.15264/cpho.2022.29.1.21
이용수
초록· 키워드
오류제보하기
Acquired hemophilia A (AHA) is a rare bleeding disorder, especially in adolescents and young adults (AYAs) attributable to the development of autoantibodies against coagulation factor VIII (FVIII). AHA diagnosis is difficult; patients lack any history of coagulopathy. We report here on an AYA with AHA who responded well to treatment. A 19-year-old woman visited our hospital with painful swelling of the right lower leg. She had no past or familial history of a bleeding disorder. The initial laboratory data revealed a prolonged activated partial thromboplastin time and an uncorrected mixing test result. The FVIII activity was below 1% and the FVIII antibody level 22.4 Bethesda units. She was diagnosed with AHA and treated with recombinant activated coagulation factor VII, activated prothrombin complex concentrates and an oral steroid. After 9 months, FVIII antibody level was negative and the FVIII activity was normalized. AHA is very rare especially in AYAs, but physicians must be suspi-cious about the disorder and plan specialized coagulation tests to diagnose the disease. An early diagnosis of acquired bleeding disorders should be done for initiat-ing the adequate treatment immediately by both controlling the acute bleeding epi-sode and eliminating FVIII antibodies.
목차
등록된 정보가 없습니다.
참고문헌 (0)
참고문헌 신청함께 읽어보면 좋을 논문
논문 유사도에 따라 DBpia 가 추천하는 논문입니다. 함께 보면 좋을 연관 논문을 확인해보세요!
-
Spontaneous Retroperitoneal Hemorrhage Caused by Idiopathic Acquired Hemophilia A Misdiagnosed as a Delayed Traumatic Hematoma: A Case Report
Journal of Acute Care Surgery
2019 .01
-
Impact of ABO blood group antigens on residual factor VIII levels and risk of inhibitor development in hemophilia A
Blood Research
2023 .03
-
The activity of factor VIII and IX of cord blood at mid-trimester in fetuses without hemophilia
Journal of genetic medicine
2016 .01
-
Coagulation Factor Activity and Hemostatic Markers of Endothelial Dysfunction in Patients with Peripheral Arterial Disease
Vascular Specialist International
2021 .09
-
Management of Malignancies Developing in AYA
Clinical Pediatric Hematology-Oncology
2021 .01
-
Comparative evaluation of the safety and efficacy of recombinant FVIII in severe hemophilia A patients
Journal of Pharmacopuncture
2018 .01
-
Acquired Hemophilia A with Gastrointestinal Bleeding
Clinical Endoscopy
2020 .01
-
Rare bleeding disorders: spectrum of disease and clinical manifestations in the Pakistani population
Blood Research
2020 .01
-
FVIII inhibitor surveillance in children with hemophilia A in Indonesia: a report from the Indonesian Pediatric Hematology-Oncology Working Group
Blood Research
2022 .12
-
Mining of mortality-related findings in rare bleeding disorders: a retrospective study from two centers
Blood Research
2020 .01
-
Evaluation of FVIII pharmacokinetic profiles in Korean hemophilia A patients assessed with myPKFiT: a retrospective chart review
Blood Research
2024 .09
-
Autoimmune Hepatic Failure Following Acute Hepatitis A is Accompanied by Inflammatory Conversion of Regulatory T Cells
Yonsei Medical Journal
2020 .01
-
출혈시간 검사에 대한 임상적 유용성: 체계적 문헌고찰
보건의료기술평가
2022 .12
-
Recombinant von Willebrand Factor for Pediatric Patient with von Willebrand Disease: First Report in Korea
Clinical Pediatric Hematology-Oncology
2021 .01
-
Comparative Analysis of Liver Injury-Associated Cytokines in Acute Hepatitis A and B
Yonsei Medical Journal
2016 .01
-
가정 내 일상생활활동 평가의 신뢰도 및 타당도 연구
대한작업치료학회지
2015 .01
-
Perioperative Management and Outcomes in Children with Hereditary Bleeding Disorder: a Retrospective Review at a Singl e Hemophilia Treatment Center
Clinical Pediatric Hematology-Oncology
2020 .01
-
혈액응고인자 제제와 지혈제
대한수혈학회지
2021 .01
이 논문의 저자 정보
최근 본 자료
댓글(0)
0